Early Oral Antibiotic Switch for Staphylococcus aureus Bacteremia: Many Are Called, but Few Are Chosen.

Journal Article (Journal Article)

Staphylococcus aureus bacteremia (SAB) is a complicated, high-risk disease. For selected low-risk SAB, the role of oral antibiotic stepdown therapy is unknown. Bupha-Intr et al. report a retrospective cohort of low-risk SAB patients who did well with a short duration of intravenous antibiotics, followed by an additional ∼10 days of oral antibiotics, primarily using beta-lactams. Prospective trials will help further define the efficacy of this approach.

Full Text

Duke Authors

Cited Authors

  • Holland, TL

Published Date

  • June 23, 2020

Published In

Volume / Issue

  • 64 / 7

PubMed ID

  • 32393495

Pubmed Central ID

  • PMC7317999

Electronic International Standard Serial Number (EISSN)

  • 1098-6596

Digital Object Identifier (DOI)

  • 10.1128/AAC.00317-20


  • eng

Conference Location

  • United States